文献速递心血管MRUS

心脏MRI衍生的主动脉僵硬度与射血分数保留型心力衰竭早期阶段及进展的关联

Association of Cardiac MRI-derived Aortic Stiffness with Early Stages and Progression of Heart Failure with Preserved Ejection Fraction.
PubMed 文献 · Radiol Cardiothorac Imaging · 2024-01-01

本研究为前瞻性HFpEF负荷试验的二次分析,纳入48例参与者,比较非心源性呼吸困难、静息隐匿性与静息显性HFpEF患者的主动脉脉搏波速度。结果显示HFpEF患者主动脉脉搏波速度升高,且与肺毛细血管楔压、心肌应变及NT-proBNP相关;主动脉僵硬度在多变量分析中与HFpEF独立相关。临床前研究显示诱导动脉僵硬的转基因小鼠表现出HFpEF表型。

要点

  • 心脏MRI测量的主动脉脉搏波速度在隐匿性和显性HFpEF患者中均高于非心源性呼吸困难者。
  • 主动脉脉搏波速度升高与肺毛细血管楔压升高、左房和左室长轴应变及NT-proBNP水平相关。
  • 主动脉僵硬度在多变量分析中与HFpEF独立相关(OR 1.31,P=0.049)。

核心结论

  • 研究提供转化证据表明主动脉僵硬度增加可能与HFpEF的发生和进展相关,并可能有助于其早期检测。

研究设计与样本

  • 临床研究为前瞻性HFpEF负荷试验(2017年8月至2019年9月)的二次分析,纳入48例参与者(中位年龄69岁,范围65-73岁;女性33例,男性15例),分为非心源性呼吸困难组(n=21)、静息显性HFpEF组(PCWP≥15 mmHg,n=14)和运动负荷时诊断的静息隐匿性HFpEF组(PCWP≥25 mmHg,n=13),均经右心导管检查确诊;所有参与者接受静息和运动负荷下的超声心动图和心脏MRI检查,计算主动脉脉搏波速度。临床前研究为诱导动脉僵硬的Runx2-smTg转基因小鼠,表征心脏功能和结构。

关键影像表现/征象

  • Runx2-smTg小鼠与野生型对照相比表现出「HFpEF」表型:左室缩短分数保留,但舒张早期和晚期二尖瓣环速度小于1(均值0.67±0.39 vs 1.45±0.47,P=0.004),心肌胶原沉积增加(均值11%±1 vs 2%±1,P<0.001),脑钠肽水平升高(均值171 pg/mL±23 vs 101 pg/mL±10,P<0.001)。

诊断标准与关键数值

  • 静息显性HFpEF定义为右心导管检查肺毛细血管楔压≥15 mmHg;运动负荷时诊断的静息隐匿性HFpEF定义为运动负荷时肺毛细血管楔压≥25 mmHg;非心源性呼吸困难组作为对照。主动脉脉搏波速度中位数:非心源性呼吸困难组7.0 m/sec(IQR 5.0-9.5),隐匿性HFpEF组10.0 m/sec(IQR 8.0-13.4),显性HFpEF组11.0 m/sec(IQR 7.5-12.0);非心源性呼吸困难组 vs 隐匿性HFpEF组P=0.005,非心源性呼吸困难组 vs 显性HFpEF组P=0.01。显性HFpEF组native T1时间高于非心源性呼吸困难组(1234 msec [IQR 1208-1255] vs 1199 msec [IQR 1169-1228],P=0.009)。多变量分析中主动脉僵硬度与HFpEF独立相关(OR 1.31,P=0.049)。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To investigate if aortic stiffening as detected with cardiac MRI is an early phenomenon in the development and progression of heart failure with preserved ejection fraction (HFpEF). Materials and Methods Both clinical and preclinical studies were performed. The clinical study was a secondary analysis of the prospective HFpEF stress trial (August 2017 through September 2019) and included 48 participants (median age, 69 years [range, 65-73 years]; 33 female, 15 male) with noncardiac dyspnea (NCD, n = 21), overt HFpEF at rest (pulmonary capillary wedge pressure [PCWP] ≥ 15 mm Hg, n = 14), and masked HFpEF at rest diagnosed during exercise stress (PCWP ≥ 25 mm Hg, n = 13) according to right heart catheterization. Additionally, all participants underwent echocardiography and cardiac MRI at rest and during exercise stress. Aortic pulse wave velocity (PWV) was calculated. The mechanistic preclinical study characterized cardiac function and structure in transgenic mice with induced arterial stiffness (Runx2-smTg mice). Statistical analyses comprised nonparametric and parametric comparisons, Spearman correlations, and logistic regression models. Results Participants with HFpEF showed increased PWV (NCD vs masked HFpEF: 7.0 m/sec [IQR: 5.0-9.5 m/sec] vs 10.0 m/sec [IQR: 8.0-13.4 m/sec], P = .005; NCD vs overt HFpEF: 7.0 m/sec [IQR: 5.0-9.5 m/sec] vs 11.0 m/sec [IQR: 7.5-12.0 m/sec], P = .01). Increased PWV correlated with higher PCWP (P = .006), left atrial and left ventricular long-axis strain (all P < .02), and N-terminal pro-brain natriuretic peptide levels (P < .001). Participants with overt HFpEF had higher levels of myocardial fibrosis, as demonstrated by increased native T1 times (1199 msec [IQR: 1169-1228 msec] vs 1234 msec [IQR: 1208-1255 msec], P = .009). Aortic stiffness was independently associated with HFpEF on multivariable analyses (odds ratio, 1.31; P = .049). Runx2-smTG mice exhibited an "HFpEF" phenotype compared with wild-type controls, with preserved left ventricular fractional shortening but an early and late diastolic mitral annulus velocity less than 1 (mean, 0.67 ± 0.39 [standard error of the mean] vs 1.45 ± 0.47; P = .004), increased myocardial collagen deposition (mean, 11% ± 1 vs 2% ± 1; P < .001), and increased brain natriuretic peptide levels (mean, 171 pg/mL ± 23 vs 101 pg/mL ± 10; P < .001). Conclusion This study provides translational evidence that increased arterial stiffness might be associated with development and progression of HFpEF and may facilitate its early detection. Keywords: MR Functional Imaging, MR Imaging, Animal Studies, Cardiac, Aorta, Heart ClinicalTrials.gov identifier NCT03260621 Supplemental material is available for this article. © RSNA, 2024.

来源:Radiol Cardiothorac Imaging,查看原文。版权归原作者所有。

引用

  1. Schulz A, Schellinger IN, Backhaus SJ, et al. Association of Cardiac MRI-derived Aortic Stiffness with Early Stages and Progression of Heart Failure with Preserved Ejection Fraction. Radiol Cardiothorac Imaging. 2024. PMID: 39145733. doi:10.1148/ryct.230344

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。